VKH
SAGE

Virtu KCG Holdings’s Sage Therapeutics SAGE Stock Holding History

Virtu KCG Holdings’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,579
Closed -$243K – 3285
2016
Q1 		$243K Buy
+7,579
New +$267K 0.01% 1897
2015
Q4 		– Sell
-5,473
Closed -$232K – 3882
2015
Q3 		$232K Buy
+5,473
New +$337K ﹤0.01% 2406

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Virtu KCG Holdings's SAGE Position: Q2 2016 in Review

Virtu KCG Holdings sold out of Sage Therapeutics (SAGE) in Q2 2016, closing a stake of 7,579 shares — an estimated $243K sold.

Virtu KCG Holdings first reported a position in SAGE in Q3 2015 and held it in 2 quarters. The position peaked at $243K in Q1 2016. 145 funds tracked by Wall St. Rank hold SAGE as of Q2 2016.

  • Virtu KCG Holdings reported no remaining Sage Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 7,579 Sage Therapeutics shares in Q2 2016, an estimated $243K.
  • Virtu KCG Holdings first reported a position in Sage Therapeutics in Q3 2015 and held it in 2 quarters.
  • Virtu KCG Holdings's Sage Therapeutics position peaked at $243K in Q1 2016.
  • 145 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2016.

Based on Virtu KCG Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.